SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Machado Patrick

(Last) (First) (Middle)
3000 KENT AVE., SUITE A1-100

(Street)
WEST LAFAYETTE IN 47906

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/27/2018
3. Issuer Name and Ticker or Trading Symbol
ENDOCYTE INC [ ECYT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Beth A. Taylor, Attorney-in-Fact for Patrick Machado (power of attorney filed herewith) 03/01/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Limited Power of Attorney Securities Law 
Compliance

The undersigned, as an officer or 
director of Endocyte, Inc. (the 
"Company"), hereby constitutes and 
appoints Michael A. Sherman and Beth A. 
Taylor, and each of them, the 
undersigned's true and lawful attorney in 
fact and agent to complete and execute 
such Forms 144, Forms 3, 4 and 5, Form ID 
and other forms as such attorney shall in 
his or her discretion determine to be 
required or advisable pursuant to Rule 
144 promulgated under the Securities Act 
of 1933 (as amended), Section 16 of the 
Securities Exchange Act of 1934 (as 
amended) and the rules and regulations 
promulgated thereunder, or any successor 
laws and regulations, as a consequence of 
the undersigned's ownership, acquisition 
or disposition of securities of the 
Company, and to do all acts necessary in 
order to file such forms with the 
Securities and Exchange Commission, any 
securities exchange or national 
association, the Company and such other 
person or agency as the attorney shall 
deem appropriate.  The undersigned hereby 
ratifies and confirms all that said 
attorneys in fact and agents shall do or 
cause to be done by virtue hereof.

This Limited Power of Attorney shall 
remain in full force and effect until
 the 
undersigned is no longer required to file 
Forms 144, Forms 3, 4 and 5 or Forms ID 
with respect to the undersigned's 
holdings of and transactions in 
securities issued by the Company unless 
earlier revoked by the undersigned in a 
writing delivered to the foregoing 
attorneys-in-fact.

This Limited Power of Attorney is 
executed as of the date set forth below.

/s/ Patrick Machado	                         
Signature

Patrick Machado                                 
Type or Print Name

Dated:    28-Feb-18                       


Witness:

/s/ Fenella L. Harris                             
Signature

Fenella L. Harris                                 
Type or Print Name

Dated:     28-Feb-18                      

US.115887916.02